A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
China
Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality Sun Yat-sen University Cancer Center, Guangzhou, Guangdong The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Renmin Hospital of Wuhan University, Wuhan, Hubei Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Hunan Cancer Hospital, Changsha, Hunan Shanghai Oriental Hospital, Shanghai, Shanghai Municipality Shanxi Cancer Hospital, Taiyuan, Shanxi Last updated September 2025